Logo for ImmunoPrecise Antibodies Ltd

ImmunoPrecise Antibodies Investor Relations Material

Latest events

Logo for ImmunoPrecise Antibodies Ltd

Q2 2024

ImmunoPrecise Antibodies
Logo for ImmunoPrecise Antibodies

Q2 2024

14 Dec, 2023
Logo for ImmunoPrecise Antibodies

Q1 2024

14 Sep, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Segment Data
Access more data
Revenue by
Geography
Europe
U.S.
Australia
Canada
Other
Expenses by
Financials
ImmunoPrecise Antibodies Ltd. engages in antibody production and related services worldwide. It offers purification and affinity maturation of monoclonal antibodies; design, development, and validation of comprehensive service packages for the discovery of novel antibodies against therapeutic targets; custom peptide synthesis services; recombinant protein expression platforms; custom vaccines and neutralizing antibodies for passive transfer applications; and an in vivo passive transfer model for assessing the efficacy of passive immune treatments targeting infectious diseases.